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Human Enhancement and Experimental Research in the Military
EFTHIMIOS PARASIDIS
For over a century the U.S. military has conducted and sponsored cutting-edge medical and technological research. While such projects have often resulted in transformative innovations, in a number of instances, researchers have deliberately violated legal requirements and/or ethical norms governing research with human subjects. This Article explores these matters by discussing the history of misfeasance in military research and examining contemporary military endeavors that aim to exploit biomedical advancements.
computer communication via thought alone. 3 In addition to increased health risks associated with enhancement techniques, a number of challenging legal and bioethical issues have been insufficiently explored. Should enhancements be a mandatory aspect of military service? Who determines the parameters for an acceptable riskbenefit profile? What remedies should be available for service members who experience adverse health effects? Adequately addressing these concerns, particularly in the context of military hierarchy and demography, provides a socio-medical framework that facilitates sensible harmonization of national security interests with fundamental notions of human dignity and patient autonomy.
II. A HISTORY OF UNCONSCIONABLE RESEARCH
The atrocities committed by German military researchers during World War II challenged the international community to directly address safeguards governing experimental research on human subjects. While the U.S. military played an integral role in the prosecution of the German researchers and the drafting of the Nuremburg Code, the U.S. government failed to publicly disclose its involvement in unethical, if not illegal, experimental research on American civilians and service members. 4 Three examples include studies related to mustard gas, nuclear weapons, and psychotropic drugs.
The mustard gas experiments involved approximately 60,000 American soldiers in "race-based human experimentation" that sought to determine whether race or skin complexion influences one's susceptibility to injuries from mustard gas. 5 Researchers created "man-break" tests 3 See MORENO, supra note 2, at 51 (discussing innovations in the "'human-computer' combination"); Annas & Annas, supra note 2, at 285-86 (describing projects that seek technologies which would make it possible for soldiers to perform for several days without sleep); Hannah Hoag, Remote Control, 423 NATURE 796, 796 (2003) whereby service members were locked in gas chambers that were inundated with mustard gas until the point that the men became incapacitated. 6 During the experiments, some soldiers were exposed to gas levels that were equivalent to those reported on World War I battlefields.
7
The "man-break" tests caused severe injuries to the service members. Soldiers experienced "immediate and severe eye injuries" and "enormous, grotesque blisters and oozing sores" on their "face, hands, underarms, buttocks, and genitals."
8 Exposure to mustard gas also caused blindness, intense vomiting, internal and external bleeding, and damage to the lungs and respiratory system. 9 Many soldiers suffered long-term health effects that included cancer, asthma, and psychological disorders.
10
For decades, the U.S. government refused to acknowledge the existence of the studies or provide injured service members with compensation or long-term health care. It was not until 1991-nearly five decades after the first studies began-that the government officially admitted to the use of soldiers in experimental research. The government also admitted that it did not fully disclose safety risks or obtain informed consent from the research participants, and that the service members may have suffered adverse health effects as a result of their participation in the studies.
11
Contemporaneous with the mustard gas experiments, the U.S. military conducted radiation experiments on American soldiers and civilians.
12 In addition to testing the destructive capabilities of nuclear weapons, military researchers examined the effects of nuclear warfare on humans, animals, and the environment. 13 As early as 1942, the military understood that exposure to radiation was likely to be quite dangerous, since "the deleterious effects of radiation could not be seen or felt and the results of over-exposure might not become apparent for long periods after such exposure." After years of detonating atomic weapons in the South Pacific, the military began open air testing of nuclear weapons on American soil in the 1950s. 15 Thousands of soldiers were placed, without protective clothing, in the immediate vicinity of atomic detonations. The military did not inform the soldiers of potential health risks or seek to obtain informed consent prior to participation in the trials.
While the military publicly denied any potential harm to humans, plants, or animals, internal documents indicate that government officials had determined that there existed a causal relationship between radiation exposure and serious adverse health effects. 16 Despite the health and environmental hazards, the Commissioner of the U.S. Atomic Energy Commission privately asserted that "[w]e must not let anything interfere with this series of tests-nothing."
17 It was later revealed that radiation exposure at the test sites was comparable to that of Hiroshima and Nagasaki.
18
Coupled with the open-air nuclear tests, the military funded studies at a number of well-respected American universities, including the University of Chicago and the University of California, whereby researchers injected unsuspecting civilians with radioactive elements that included plutonium, uranium, and polonium. 19 This work continued through the 1970s, with researchers targeting the elderly, patients in mental institutions, prisoners, and others "who did not have full faculties for informed consent." 20 A congressional investigation later found that "[n]o evidence was elicited that informed consent was granted in any of the cases," and that "[t]he government covered up the nature of the experiments and deceived the families of deceased victims . . . ."
21
In the 1990s, the government acknowledged that hundreds of thousands of American service members had been involved in at least 1400 radiation projects over a thirty-year period during and after World War II.
22
These figures do not include exposure suffered by American civilians in connection with hundreds of "intentional radiation releases," where 15 See Howard Ball, Downwind from the Bomb, N.Y. TIMES, Feb. 9, 1986, ( § 6), at 33 (recounting the history of American nuclear testing beginning in the 1950s). Approximately one hundred atomic detonations occurred on U.S. soil during the 1950s. Id. 16 Id. 17 Id. 18 See Schroeter, supra note 13, at 213. 19 See Human Radiation Experiments Report, supra note 4, at 160-61. 20 See Schroeter, supra note 13, at 157-58. For example, the Massachusetts Institute of Technology fed elderly patients radium and thorium, two radioactive elements that could have no benefit to the test subjects. Id. at 158. Over a period of eight years, the University of Washington Medical School x-rayed the testes of prisoners to examine the effects of ionizing radiation on human fertility and testicular function. Id. 21 Id. at 157-58. 22 Schroeter, supra note 13, at 151.
researchers deliberately emitted radioactive substances into densely populated cities and other locations to test human response and environmental contamination. 23 Although the government was aware that the radiation releases were likely to contaminate food and water supplies, many of the releases "took place with no public awareness or understanding." 24 Within ten years after the commencement of the detonations in America, childhood leukemia deaths and diagnoses, as well as adult cancer deaths and diagnoses, were exponentially higher in several detonation regions. 25 Along with the mustard gas and radiation experiments, the U.S. military engaged in decades of classified research, beginning in the 1940s and continuing through the 1970s, to ascertain whether psychotropic drugs could be used as chemical weapons or interrogation-facilitating agents.
26
The products under investigation included lysergic acid diethylamide (LSD), synthetic mescaline, synthetic marijuana, and over a dozen other drugs. During the early stages of the research, the U.S. military recruited Nazi scientists who had studied and participated in torture and brainwashing.
27 Several of the Germans had been recently identified as war criminals, and the U.S. falsified documents to conceal their true identities. 28 The military later justified its actions by arguing that national security interests far outweighed any ethical concerns.
29
The psychotropic drugs were given to service members and civilians without their knowledge or consent. 30 Studies were conducted in military facilities and university medical centers, and many human subjects experienced serious adverse side effects. 31 Internally, the military justified the secret testing on "'unwitting, nonvolunteer' Americans" by arguing that national security interests permit "a more tolerant interpretation of moral-ethical values, but not legal limits. There is nothing to suggest that the U.S. military is currently supporting research that utilizes methods similar to those employed during the mustard gas, radiation, or psychotropic drug experiments. However, recent controversies have highlighted the military's efforts to mandate use of medical products for off-label or investigational purposes, and its emphasis on developing biotechnologies that seek to facilitate the cognitive and physical enhancement of service members. 34 This Part will focus on these two areas of research.
A. Investigational and Off-Label Use of Medical Products
Since at least the 1990s, the U.S. military has required service members to subject themselves to both investigational and off-label use of medical products.
35
Both off-label and investigational use involve utilization of a medical product for an indication that has not earned FDA approval. 36 While each is properly characterized as experimental research because the FDA has not found that the underlying product is safe and effective for the stated use, there is an important distinction between the two categories. For products that are used off-label, the FDA has determined that the product is safe and effective for at least one indication. 37 Investigational medical products, on the other hand, have not been approved for any indication.
38
Nonconsensual use of off-label or investigational medical products raises a number of serious concerns. While physicians may prescribe drugs for off-label indications or investigational purposes, the decision to do so must be based on an evaluation of a patient's particular health 33 Id. at 689. 34 See Annas & Annas, supra note 2, at 301-04 (discussing how, in the war on terror, physicians have participated in prisoner interrogations and prisoner hunger strikes, and the military has prescribed psychotropic medications, particularly selective serotonin-reuptake inhibitors, to soldiers in order to keep them in combat areas or to have them serve another tour of duty). 35 condition and risk factors, and should only occur where medical data reflect meaningful evidence that the potential benefits are likely to outweigh the known or expected risks and the patient provides informed consent to the treatment. In a number of instances, the military has made off-label and investigational use of medical products compulsory for service members as a whole, and has not sought to obtain informed consent or provide adequate risk disclosures to individual soldiers. The discussion below explores four recent examples-pyridostigmine bromide ("PB"), the botulinum toxoid ("BT") vaccine, the anthrax vaccine, and selective serotonin reuptake inhibitors ("SSRIs").
After petitioning the FDA to establish a new rule that waives informed consent requirements for investigational use of medical products in times of existing or anticipated combat activities, the DoD sought and obtained permission from the FDA to use PB and the BT vaccine pursuant to the new regulation. 39 Fearing use of chemical weapons during the Gulf War, the military decided to administer PB and the BT vaccine to all soldiers. 40 At the time, the FDA was evaluating the safety and efficacy of both products as pretreatments for chemical warfare. 41 In its informed consent waiver request to the FDA, the DoD argued that it would not be feasible to obtain informed consent because a soldier's "personal preference" does not supersede the military's view that the drug and vaccine would contribute to the "safety of other personnel in a soldier's unit and the accomplishment of the combat mission." 42 The DoD also argued that "obtaining informed consent in the heat of imminent or ongoing combat would not be practicable." 43 The FDA granted the DoD's requests, but the decision was not without controversy. The DoD claims that it trusted that the FDA had granted permission to use the investigational drug without informed consent because the FDA believed that the drug was deemed to be safe. 44 The FDA, on the other hand, claims that it granted the waiver because it believed that the DoD determined that military necessity required an informed consent waiver. 45 Regardless of the reason why the FDA granted the waiver, as a condition of the FDA's permission to use the investigational medical products without informed consent, the DoD agreed to: (1) provide information on PB to all service members; (2) collect, review, and make 39 Doe v. Sullivan, 938 F.2d 1370, 1372 n.1, 1374 (D.C. Cir. 1991). 40 Id. at 1371-72, 1372 n.1. 41 Id. at 1372 n.1. 42 Id. at 1373. 43 Id. 44 Annas & Annas, supra note 2, at 301-02. 45 Id. at 302.
reports of adverse events related to PB; (3) label PB as an investigational product that was solely for "military use and evaluation;" (4) ensure that each dose of the BT vaccine was recorded in each service member's medical record; and (5) maintain adequate records related to the receipt, shipment, and disposition of the BT vaccine. 46 The DoD failed to comply with each of these requirements. 47 Following use of PB and the BT vaccine during the Gulf War, veterans began suffering from serious health problems that include cognitive difficulties, chronic headaches, widespread pain, skin rashes, respiratory and gastrointestinal problems, and other chronic abnormalities. 48 Gulf War veterans have been diagnosed with amyotrophic lateral sclerosis ("ALS") at a much higher rate than that of the general population or veteran populations from other wars. 49 Children of Gulf War veterans are also born with birth defects at an alarming rate. 50 Commonly referred to as Gulf War illness, these health problems affect over 175,000 Gulf War veterans, which amounts to more than twenty-five percent of the fighting force during the war.
51 PB is included in the list of factors that are most likely to be a contributing factor to Gulf War illness.
52
The military's off-label use of vaccines continued after the Gulf War. In 1998, the DoD implemented the Anthrax Vaccine Immunization Program ("AVIP"), which requires the anthrax vaccine for all service members who are deemed by DoD to be at risk for anthrax exposure. cutaneous anthrax, the military sought to use the vaccine as a pretreatment for inhalation anthrax.
54
In 2003, six service members filed a lawsuit seeking to enjoin the military from continuing AVIP because the military did not obtain informed consent prior to inoculations, nor did the DoD obtain a waiver for the informed consent requirements.
55
A federal district court issued a preliminary injunction that halted AVIP. 56 Days later, the FDA approved the anthrax vaccine "independent of the route of exposure," which captured the indication of inhalation anthrax. 57 The court then vacated the FDA's decision on procedural grounds because the agency did not follow its requirement to certify that the vaccine was safe and effective against inhalation anthrax.
58 In essence, the court found it impossible for the FDA to have adequately evaluated the products, pursuant to the statutory requirements, in such a short time period.
Congress stepped in to aid the DoD by enacting the Project BioShield Act of 2004, 59 which granted the FDA the ability to permit off-label or investigational use of medical products during a declared emergency. 60 In turn, the FDA used its newfound power to grant the DoD the ability to continue using the anthrax vaccine. 61 During the time that the DoD was permitted to continue with AVIP pursuant to the emergency order, the FDA approved the vaccine regardless of the route of exposure.
62 Although service members once again challenged the FDA's decision, the Court of Appeals for the D.C. Circuit dismissed the action because it found that the FDA had not acted arbitrarily or capriciously in approving the new indication during its second review.
63 Since March 1998, over 2,700,000 service members have received the anthrax vaccine. 64 For a number of 54 Id. at 863-64. 55 Id. 56 Id. at 864. 57 Id. at 863-64. 58 Id. at 864. 59 21 U.S.C. § 360bbb-3 (2006). 60 See Nightingale et al., supra note 35, at 1046 (describing the Project BioShield Act's establishment of the comprehensive Emergency Use Authorization ("EUA") program, which permits the FDA to "approve the emergency use of drugs, devices, and medical products . . . that were not previously approved, cleared, or licensed by FDA . . . or the off-label use of approved products in certain well−defined emergency situations"). 61 Id. at 1050. 62 See Rempfer, 583 F.3d at 864 (stating that, after issuing a proposed order for comment and reviewing those comments, the FDA issued a new final order on December 19, 2005 that classified the anthrax vaccine as "safe and effective in the prevention of anthrax regardless of the route of exposure"). 63 Id. at 867-68. 64 See Why Get Vaccinated, BIOTHRAX, http://www.biothrax.com/whatisbiothrax/ whygetvaccinated.aspx, (last visited Feb. 16, 2012) (stating that more than 10 million doses of BioThrax Anthrax Vaccine have been administered to 2.7 million people); see also Anthrax Vaccine service members, however, the administration of the vaccine is not reflected in the official medical records maintained by the military. 65 Today, some of the most pressing medical issues facing service members include traumatic brain injury ("TBI"), post-traumatic stress disorder ("PTSD"), and other mental health issues. 66 A decade of intense fighting in Afghanistan and Iraq has resulted in a "substantial mental health burden for war veterans and their families." 67 Blast-related TBI has been labeled the signature injury of the wars, and countless soldiers have reported post-concussive symptoms. 68 Veterans of these wars have required mental health treatment for serious mental disorders much more than veterans of previous wars, and suicide rates for enlisted service members and veterans are at an all-time high. 69 Increasingly, treatments for depression, TBI, PTSD, and anxiety disorders utilize newer psychotropic medications, particularly selective serotonin-reuptake inhibitors. 70 Military psychiatrists have recommended that physicians in war zones have SSRIs "in large quantities, to be used for both depressive disorders and anxiety disorders." 71 However, a number of studies have questioned the safety and efficacy of SSRIs. 72 Off-label use of SSRIs is particularly troubling, with some studies finding no meaningful clinical benefit and long-term adverse health effects. 73 To the extent that SSRIs are the standard of care for both on-label and off-label indications, and service members are not provided with accurate risk-benefit profiles, such use may place service members at a heightened risk for both shortterm and long-term health problems.
B. Physical and Cognitive Enhancement of Service Members
The fundamental goal of military training is to enhance service members-to make them smarter, stronger, and more able fighters. Increasingly, enhancement techniques have sought to leverage innovative medical products and technologies. As the director of DARPA explains, the agency's goal is to exploit "the life sciences to make the individual warfighter stronger, more alert, more endurant, and better able to heal." 75 Such endeavors have raised a number of challenging questions. Is there a valid distinction between "artificial" and "natural" enhancement? Under what circumstances should enhancements that are under development be administered to service members? Should medical enhancements ever be a required aspect of service in the military? Examining current enhancement projects helps frame these concerns.
DARPA The former is "investigating ways to prevent fatigue and enable soldiers to stay awake, alert, and effective for up to seven days straight without suffering any deleterious mental or physical effects and without using any of the current generation of stimulants." 87 The latter incorporates neuroscientific studies such as Though DARPA-funded research is often cutting-edge and visionary, about ninety percent of its projects fail. 89 Those that succeed, however, 82 Hoag, supra note 3, at 798. 83 Id. at 796, 798. 84 Id. at 796. 85 MORENO, supra note 2, at 127. 86 Id. at 11-13. 87 Id. at 11 (internal quotation marks omitted). 88 Id. at 12-13. 89 Id. at 12.
often prove transformative for both military and civilian life. 90 DARPAfunded research has resulted in the creation of the Internet (initially called the Darpanet), the computer mouse, the Stealth Fighter, and unmanned aerial vehicles. 91 As one DARPA official explains, "DARPA is about trying to do those things, which are thought to be impossible, and finding ways to make them happen." 92 
IV. CONCLUSION
I have focused my discussion in this Article on military medicine and research methods employed by the U.S. military in furtherance of its mandate to protect national security interests. One need not question the validity of the government's motivations to conduct experimental research to understand that current and past research methods run contrary to fundamental constitutional liberties and well-established research protocols governing human subjects research.
Importantly, the unique relationship between a service member and his or her commanding officer, and in turn, between the commanding officer and his or her superiors, creates an environment with enormous potential for abuse from a socio-medical context. Service members are legally obligated to submit to biomedical treatments deemed necessary for the good of the armed forces, even in instances where the treatments are purely investigational or involve unapproved uses of FDA-approved medical products. 93 Refusing "treatment" may be viewed as disobeying an order, which can result in punitive measures that include a court-martial and dishonorable discharge from the military. Coupled with the threat of punitive measures, military hierarchy often compels soldiers to submit to experimental treatment in instances where they otherwise may not have provided consent. 94 The risks to service members are compounded when one considers the broad legal immunities that shield military researchers and the U.S. government from civil claims. Under the Feres doctrine, service members are precluded from raising tort claims against the government, government employees, or third party contractors working in furtherance of governmental research, if the underlying injury is sustained "in the course
